Biogen (BIIB) Non-Current Debt (2009 - 2025)

Biogen (BIIB) has reported Non-Current Debt for 9 consecutive years, with $6.3 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Non-Current Debt rose 38.26% year-over-year to $6.3 billion; the TTM figure through Dec 2025 stood at $6.3 billion (up 38.26% YoY), while the FY2025 annual figure was $6.3 billion, up 38.26% from the prior year.
• Non-Current Debt came in at $6.3 billion for Q4 2025 at Biogen, up from $4.5 billion in the prior quarter.
• The five-year high for Non-Current Debt was $6.8 billion in Q4 2023, with the low at $4.5 billion in Q4 2024.
• Average Non-Current Debt over 4 years is $6.0 billion, with a median of $6.3 billion recorded in 2022.
• Across the five-year window, Non-Current Debt slumped 33.01% in 2024 and surged 38.26% in 2025, its largest moves.
• Year by year, Non-Current Debt stood at $6.3 billion in 2022, then gained by 8.08% to $6.8 billion in 2023, then plunged by 33.01% to $4.5 billion in 2024, then soared by 38.26% to $6.3 billion in 2025.
• According to Business Quant data, Non-Current Debt over the past three periods registered $6.3 billion, $4.5 billion, and $6.8 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.